TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Gilead Sciences Inc (GILD)

Healthcare Drug Manufacturers - General
130.20 $
-0.8% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Gilead Sciences Inc (GILD)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.8% of the shares are freely tradable; institutional investors hold 92.2%.

Ownership Structure

Institutional ownership
92.2%
Insiders
0.1%
Float
99.8%
Short % of float
2.0%
Shares Outstanding
1,242Mio.

Largest Shareholders

Institutions

Institutions GILD
Name Stake (%) Shares Change (%) Date
BlackRock Inc 9.59 119,010,973 -3.4 03/31/2026
Vanguard Capital Management, LLC 6.50 80,654,776 +0.0 03/31/2026
FMR Inc 5.79 71,906,290 +9.6 03/31/2026
State Street Corp 4.82 59,858,585 -0.6 03/31/2026
Amvescap Plc. 3.35 41,580,823 -4.3 03/31/2026
Capital World Investors 3.33 41,283,933 -3.7 03/31/2026
Vanguard Portfolio Management, LLC 2.83 35,129,465 +0.0 03/31/2026
JPMorgan Chase & Co 2.74 33,992,410 +47.6 03/31/2026

Funds

Funds GILD
Name Stake (%) Shares Change (%) Date
Vanguard Morn Total Stk Mkt Idx Investor 3.18 39,423,687 -0.2 06/30/2026
Vanguard 500 Index Investor 2.60 32,251,204 -0.7 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
15. Jul 2026 Mercier Johanna Chief Comm & Corp Aff Officer Sell 3,000 129.92 389,758
15. Jul 2026 Dickinson Andrew D Chief Financial Officer Sell 3,000 129.93 389,777

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?